PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists revolutionize the creation of genetically altered mice to model human disease

2013-05-02
(Press-News.org) CAMBRIDGE, Mass. (May 2, 2013) – Whitehead Institute Founding Member Rudolf Jaenisch, who helped transform the study of genetics by creating the first transgenic mouse in 1974, is again revolutionizing how genetically altered animal models are created and perhaps even redefining what species may serve as models.

"This new method is a game changer," says Jaenisch, who is also a professor of biology at MIT. "We can now make a mouse with five mutations in just three to four weeks, whereas the conventional way would take three to four years. And it's rather straightforward, probably even easier than the conventional way."

Scientists create models in mice by altering specific genes that have been associated with a given disease. The models allow for the study of the development and course of the disease and the effects of various interventions, including genetic and chemical. For the past 20 years, the creation of such models has remained relatively unchanged: scientists insert a piece of DNA into a mouse embryonic stem (ES) cell, inject the modified cell into a very early-stage embryo, called a blastocyst, then implant this developing ball of cells into a foster female mouse. The whole process can take years and tens of thousands of dollars to establish a mouse strain with, for example, a single copy of a gene "knocked out". Such knockouts can only be created in very few species, including mice and rats, whose ES cells can be grown and modified reliably.

The new approach used by scientists in Jaenisch's lab bypasses ES cells to quickly and efficiently produce mice with mutations in both copies of multiple genes. In next week's issue of the journal Cell, Haoyi Wang, Hui Yang, and Chikdu Shivalila describe their technique, which is based on a system that certain bacteria use to fend off viral attacks.

This is the first time that the system, known as CRISPR (for "clustered regularly interspaced short palindromic repeat")/Cas (for "CRISPR-associated"), has been used to alter multiple genes in a single multicellular organism. Shivalila says the process is so accessible that he expects other labs to adopt it quickly.

"For any institution or university with a core facility, we think this will be the way they will start making mice carrying specific mutations because it's a lot faster and so efficient," says Shivalila, one of Jaenisch's graduate students. "We were surprised that we could get two genes 'knocked out' at four loci very, very efficiently, about 80% efficiency. If we used TALENs, a more recent and complicated development in genetic engineering, we got 30% efficiency for just one gene."

Because the CRISPR/Cas technique can generate mutant mice even without using ES cells, a limitation of the conventional method for making models, genetic research may no longer be confined to a limited list of model organisms—those for which ES cells exist.

"This breaks down the definition of model organism," says Wang, a postdoctoral researcher in Jaenisch's lab. "So now, even with limited resources, any animal with established embryo manipulation procedures could be the subject of genome engineering. With many of the animals' genomes that have been sequenced, we could use this technology to establish efficient genetic manipulations in more species, to study the unique biology of each, and to learn more about evolution."

Thus, Wang, Yang, and Shivalila have used CRISPR/Cas to create mouse models only, but the team is excited broaden its application to other animals.

"We also need to see if the CRISPR/Cas system has any unexpected, undesired off-target effects, changes to the genome that we don't want," says Yang, a postdoctoral researcher in the Jaenisch lab. "So we need study this further to establish the fidelity of the system. But I think this will be the way to go."

### This research was supported by Damon Runyon Cancer Research Foundation, Croucher Foundation, National Institutes of Health (NIH) grants R37-HD045022 and R01-CA084198. Jaenisch is an adviser to Stemgent and a cofounder of Fate Therapeutics.

Written by Nicole Giese Rura

Rudolf Jaenisch's primary affiliation is with Whitehead Institute for Biomedical Research, where his laboratory is located and all his research is conducted. He is also a professor of biology at Massachusetts Institute of Technology.

Full Citation:

"One-step generation of mice carrying mutations in multiple genes by CRISPR-Cas mediated genome engineering"

Cell, May 9, 2013

Haoyi Wang (1,7), Hui Yang (1,7), Chikdu S. Shivalila (1,2,7) , Meelad M. Dawlaty (1), Albert W. Cheng (1,3), Feng Zhang (5,6), Rudolf Jaenisch (1,3,8).

1.Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA 2. Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA 3. Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA 5. Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA 02142, USA 6. McGovern Institute for Brain Research, Department of Brain and Cognitive Sciences, Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. 7. These authors contributed equally to this work. END


ELSE PRESS RELEASES FROM THIS DATE:

Bigger birth weight babies at greater risk of autism

2013-05-02
It is the first time that a clear link has been made between babies who grow to above average size at birth and risk of Autism Spectrum Disorder and follows from a study of more than 40,000 child health records in Sweden. The research, led by The University of Manchester, also confirms earlier research which reported that premature and poorly grown, low weight babies appear more susceptible to the condition. Autism affects how individuals interact with the world and with other people and there is no known cure. One child in 100 has the condition in the UK according ...

No greater death risk for children admitted to emergency out-of-hours intensive care

2013-05-02
Children admitted to UK intensive care units in out-of-hours emergencies are at no greater risk of dying than children arriving during normal working hours, according to new research. However, mortality rates are significantly higher in the winter, even after taking into account added health risks for children in the colder months. The study, published by researchers at the University of Leeds and the University of Leicester in the Journal of Pediatrics, is the first large-scale analysis of the influence of admission times on deaths in paediatric intensive care units. ...

Newly-discovered human fat cell opens up new opportunities for future treatment of obesity

2013-05-02
The body's brown fat cells play a key role in the development of obesity and diabetes. Researchers at Sahlgrenska Academy, University of Gothenburg, Sweden, have now discovered that we humans have two different kinds of brown fat cells and not one kind as previously thought. This discovery, now published in Nature Medicine, opens up new opportunities for future medicines that exploit the brown fat cells' ability to consume calories. Unlike white fat cells, which store the body's surplus energy in the form of fat, brown fat cells have the unique property of being able ...

Exercise proves to be ineffective against care home depression

2013-05-02
Researchers at the University of Warwick and Queen Mary, University of London have shown that exercise is not effective in reducing burden of depression among elderly care home residents. Exercise is a low risk intervention that can improve mental health but the findings of a National Institute for Health Research Health Technology Assessment Programme study, published in The Lancet, conclude that there is a requirement for alternative approaches to reduce the burden of depression in frail, very elderly, care home residents. The large randomised controlled trial sought ...

Stem cell discovery could aid research into new treatments

2013-05-02
Scientists have made a fundamental discovery about how the properties of embryonic stem cells are controlled. The study, which focuses on the process by which these cells renew and increase in number, could help research to find new treatments. Researchers have found that a protein, which switches on genes to allow embryonic stem cells to self-renew, works better when the natural occurring level of the protein is reduced. It was previously thought that once levels of this protein – called Oct 4 – were reduced the numbers of new stem cells being produced would also ...

More effective, cheaper concrete manufactured with ash from olive residue biomass

2013-05-02
University of Granada researchers have successfully manufactured self-compacting concrete using ash from the combustion of olive pruning residue pellets. Due to its plasticity and cohesion, this type of concrete needs no compaction when used in construction and has many advantages over conventional concrete, resulting in considerable savings of time and money. In an article published in "Construction and Building Materials", the researchers present preliminary results on the use of fly ash, produced in domestic boiler combustion of biomass olive residue pellets, as a ...

Is the humble fig more than just a fruit?

2013-05-02
Figs and fig trees are familiar to a wide cross-section of human society, both as a common food and for their spiritual importance. What is less well understood is the global nature of this association between figs and humans, which is maintained across species, continents and societies. This relationship is explored by David Wilson of Ecology and Heritage Partners and Anna Wilson from the University of Melbourne in Australia in a paper published in the Springer journal Human Ecology. Using examples from around the world, the authors show that figs are a vital resource ...

On-site asbestos detector offers promise of better workplace safety

2013-05-02
WASHINGTON, May 2, 2013—Asbestos was once called a miracle material because of its toughness and fire-resistant properties. It was used as insulation, incorporated into cement and even woven into firemen's protective clothing. Over time, however, scientists pinned the cause of lung cancers such as mesothelioma on asbestos fiber inhalation. Asbestos was banned in the many industrialized countries in the 1980s, but the threat lingers on in the ceilings, walls and floors of old buildings and homes. Now a team of researchers from the University of Hertfordshire in the U.K. ...

Unethical advertising at launch of antidepressants

2013-05-02
The new feature of the antidepressant drugs of the 1990s was that they had milder side-effects than their predecessors. Combined with aggressive marketing, this meant that annual sales in Sweden increased from just under EUR 18 million to over EUR 100 million in the space of just a few years. Most countries have an established system for self-regulation of pharmaceuticals advertising. Sweden has been held up internationally as a good example. The Swedish pharmaceutical industry's trade organisation appoints an information examiner to monitor the marketing to ensure it ...

Study uncovers mechanism for how grapes reduce heart failure associated with hypertension

2013-05-02
A study appearing in the Journal of Nutritional Biochemistry¹ demonstrates that grapes are able to reduce heart failure associated with chronic high blood pressure (hypertension) by increasing the activity of several genes responsible for antioxidant defense in the heart tissue. Grapes are a known natural source of antioxidants and other polyphenols, which researchers believe to be responsible for the beneficial effects observed with grape consumption. This study, funded by a grant from the National Institutes of Health (NIH), and conducted at the University of Michigan ...

LAST 30 PRESS RELEASES:

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

Scientists uncover novel immune mechanism in wheat tandem kinase

Three University of Virginia Engineering faculty elected as AAAS Fellows

[Press-News.org] Scientists revolutionize the creation of genetically altered mice to model human disease